Happy Thursday, Investors! In a dramatic turn of events, former Honduran President Juan Orlando Hernández — who former U.S. President Donald Trump once celebrated for “stopping drugs at a level that has never happened” — now finds himself at the center of the battlefield. Hernández has been accused of facilitating the movement of over 500 tons of cocaine through his country en route to America. Guess it never really happened after all.

And, check out the newest episode of Cannabis Insider, also available on Apple and Spotify.*

Puff Pass: Did someone forward you this email? Click here to get automatically subscribed.

TOP STORY

Former NBC Exec Brings Marijuana Brands To Life

Briefly: Today’s the day! Hope you’ve already met the stars of our California Cannabis Market Spotlight in person. If not, here’s one of the highlights.

Who It Is: BJ Carretta, a marketing and media veteran, is proof that talent can take you anywhere, from TV to sports to music to cannabis.

What He Does: The former NBC exec joined Cannabist Company Holdings in 2021 as senior VP of marketing, before transitioning to TerrasAscend in March 2023, where he performs the same role.

Why It Matters: Now among the top strategists in the cannabis space, meet BJ Carretta is one of many luminaries sharing his industry insight and expertise at today’s Benzinga Cannabis Market Spotlight in California.

Click here to read more

A MESSAGE FROM OUR PARTNERS

FIVE ZINGERS

Jushi Holdings stands out as a multi-state operator with significant market cap upside potential

$420 mandatory minimum fine for small amounts of weed proposed under new bill in Idaho

Cannabis industry's big players converge at Los Angeles event hosted by Benzinga: What to know

Agrify expects to shrink net lLoss, expand gross profit In Q4

Mexico welcomes legal CBD: Xebra Brands and ICAN pave the way with CBD supply deal

ONE FOR THE ROAD

This Cannabis Stock Is Undervalued, Says Top Analyst: Why Jushi Has An Edge In The Market

Briefly: Analysts at Zuanic & Associates gave Jushi Holdings an Overweight rating as the firm began its coverage of the marijuana company.

So Basically: According to senior analyst Pablo Zuanic, the Overweight rating for Jushi Holdings is rooted in a combination of undervaluation and strategic positioning.

So Then: Zuanic forecasts that the transition to recreational sales in these states could notably expand Jushi's EBITDA, potentially by close to 6x, and position the company for as much as 16x upside for its stock.

So What? The anticipated move to recreational cannabis in PA and VA presents a substantial growth opportunity for Jushi. With PA's medical market already valued at $1.5 billion, the shift could significantly increase the company's earnings, potentially by sixfold.

Read the full analysis here

A MESSAGE FROM OUR PARTNERS

KEEP READING

Before you go, be sure to subscribe to our other newsletters:

Ring The Bell: If you have to pick just one daily financial newsletter, it’s not a choice. Subscribe here.

The Street Sheet: A Wall Street cheat sheet, delivered every Sunday directly to your inbox. One-click subscribe here.

Future Finance: TradFi is tired. Wake up to the future of finance with this midday fintech and crypto letter. Subscribe here.

The Flag: Top takes from Washington to Wall Street impacting policy and your portfolio. One-click subscribe here.